PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy

NCT00215865 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection

Interventions

DRUG: PEGIntron plus ribavirin

Sponsor

Hepatitis Resource Network

Collaborators

[object Object]